ATRA - Atara Biotherapeutics, Inc.
5.17
0.170 3.288%
Share volume: 3,201,173
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$5.00
0.17
0.03%
Summary score
45%
Profitability
60%
Dept financing
43%
Liquidity
52%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.38%
Return on assets
-13.08%
Return on sales
-3571.67%
Return on invested capital
418.98%
Total debt ratio
125.9%
Debt ratio change over timeo
-0.93%
Current Ratio
2.05%
Quick Ratio
1.53%
Cash Position Ratio
0.79%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
12.04%
Return on sales
-20.76%
Return on invested capital
0%
Total debt ratio
198.58%
Debt ratio change over timeo
0%
Current Ratio
0.94%
Quick Ratio
0.92%
Cash Position Ratio
0.49%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-11.83%
Return on sales
-103.5%
Return on invested capital
0%
Total debt ratio
221.44%
Debt ratio change over time
0%
Current Ratio
1.02%
Quick Ratio
1.02%
Cash Position Ratio
0.32%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.26%
Return on assets
-103.33%
Return on sales
-285.77%
Return on invested capital
-71.67%
Total debt ratio
-93.44%
Debt ratio change over time
-0.93%
Current Ratio
-0.51%
Quick Ratio
-0.75%
Cash Position Ratio
-0.76%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATRA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -33.38% | 28.34% | 5.51% | 6.15% |
| Return on assets | -13.08% | 3.06% | 3.18% | 2.21% |
| Return on sales | -3571.67% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 418.98% | 6.42% | 3.22% | 6.7% |
| Profitability | 25% | 74% | 54% | 44% |
| Total debt ratio | 125.9% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | -0.93% | 12.76% | 169.64% | 13.01% |
| Dept financing | 25% | 20% | 38% | 11% |
| Current Ratio | 0.94% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0.92% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 0.49% | 0.43% | 0.63% | 0.74% |
| Liquididy | 71% | 64% | 50% | 72% |
| Short-term ratios | ATRA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 12.04% | 3.09% | 4.74% | 1.98% |
| Return on sales | -20.76% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 23% | 35% | 20% |
| Total debt ratio | 198.58% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 12% | 8% | 5% |
| Current Ratio | 0.94% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0.92% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 0.49% | 0.43% | 0.63% | 0.74% |
| Liquididy | 44% | 47% | 62% | 75% |